| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,251 |
2,193 |
$220K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,407 |
3,322 |
$197K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,961 |
1,865 |
$89K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
671 |
671 |
$56K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
545 |
545 |
$46K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
869 |
853 |
$44K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
459 |
454 |
$36K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
2,975 |
2,972 |
$27K |
| 90461 |
|
753 |
753 |
$26K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,065 |
2,062 |
$22K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
201 |
201 |
$19K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
170 |
169 |
$14K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
307 |
307 |
$10K |
| 96127 |
|
736 |
736 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
312 |
312 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
423 |
418 |
$5K |
| 92552 |
|
161 |
161 |
$4K |
| 99173 |
|
135 |
135 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
144 |
141 |
$3K |
| 87081 |
|
337 |
332 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
123 |
123 |
$2K |
| 99050 |
|
64 |
63 |
$1K |
| 87634 |
|
18 |
17 |
$1K |
| 0124A |
|
13 |
13 |
$596.44 |
| 99051 |
|
32 |
31 |
$529.92 |
| 85018 |
|
205 |
205 |
$448.40 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
16 |
16 |
$0.00 |